Product correctly added to cart.

discount label
7-Hydroxy bexarotene
View 3D

Biosynth logo

7-Hydroxy bexarotene

CAS: 368451-10-9

Ref. 3D-FH23917

50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Tuesday 7 Jan 2025

Product Information

Name:
7-Hydroxy bexarotene
Synonyms:
  • 4-[1-(5,6,7,8-Tetrahydro-7-hydroxy-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic acid
Description:

Bexarotene is a synthetic vitamin A analogue that has been used in the treatment of malignant skin tumors. It is converted to retinoic acid, which can bind to nuclear receptors and activate gene transcription. Bexarotene also has minimal activity against the growth of cancer cells in vitro. However, it does not show any clinical efficacy in patients with advanced malignancies. It may be effective in treating non-malignant diseases such as psoriasis and erythropoietic protoporphyria, but is not active against other types of cancers or against normal tissues. The drug has shown pharmacological profiles that are similar to those of retinoic acid, although it lacks some of the toxic effects associated with this drug.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
364.48 g/mol
Formula:
C24H28O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FH23917 7-Hydroxy bexarotene

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".